The long-term impact of post-procedural asymmetry and eccentricity of bioresorbable everolimus-eluting scaffold and metallic everolimus-eluting stent on clinical outcomes in the ABSORB II trial.

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Coronary artery disease - Epidemiology and outcomes 2 Revascularisation ESC Premium Access ESC Congress 2018

ESC 365 is supported by

ESC 365 is supported by